146 related articles for article (PubMed ID: 12842122)
1. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.
Mørk A; Kreilgaard M; Sánchez C
Neuropharmacology; 2003 Aug; 45(2):167-73. PubMed ID: 12842122
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of action of antidepressants: new data from Escitalopram].
Fabre V; Hamon M
Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram: a unique mechanism of action.
Bræstrup C; Sanchez C
Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
[TBL] [Abstract][Full Text] [Related]
6. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
Nguyen HT; Guiard BP; Bacq A; David DJ; David I; Quesseveur G; Gautron S; Sanchez C; Gardier AM
Br J Pharmacol; 2013 Jan; 168(1):103-16. PubMed ID: 22233336
[TBL] [Abstract][Full Text] [Related]
8. R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
Sánchez C; Kreilgaard M
Pharmacol Biochem Behav; 2004 Feb; 77(2):391-8. PubMed ID: 14751469
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
Hatanaka K; Yatsugi S; Yamaguchi T
Eur J Pharmacol; 2000 Apr; 395(1):23-9. PubMed ID: 10781669
[TBL] [Abstract][Full Text] [Related]
10. The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.
Kamińska K; Górska A; Noworyta-Sokołowska K; Wojtas A; Rogóż Z; Gołembiowska K
Pharmacol Rep; 2018 Oct; 70(5):1023-1031. PubMed ID: 30144663
[TBL] [Abstract][Full Text] [Related]
11. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
Jacquot C; David DJ; Gardier AM; Sánchez C
Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
[TBL] [Abstract][Full Text] [Related]
12. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
Sánchez C; Gruca P; Papp M
Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259
[TBL] [Abstract][Full Text] [Related]
13. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.
Invernizzi R; Belli S; Samanin R
Brain Res; 1992 Jul; 584(1-2):322-4. PubMed ID: 1515949
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity.
Mnie-Filali O; El Mansari M; Espana A; Sànchez C; Haddjeri N
Neurosci Lett; 2006 Feb; 395(1):23-7. PubMed ID: 16330146
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram versus citalopram: the surprising role of the R-enantiomer.
Sánchez C; Bøgesø KP; Ebert B; Reines EH; Braestrup C
Psychopharmacology (Berl); 2004 Jul; 174(2):163-76. PubMed ID: 15160261
[TBL] [Abstract][Full Text] [Related]
17. R-citalopram prevents the neuronal adaptive changes induced by escitalopram.
Mnie-Filali O; Faure C; Mansari ME; Lambás-Señas L; Bérod A; Zimmer L; Sánchez C; Haddjeri N
Neuroreport; 2007 Oct; 18(15):1553-6. PubMed ID: 17885600
[TBL] [Abstract][Full Text] [Related]
18. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro.
Mnie-Filali O; Lau T; Matthaeus F; Abrial E; Delcourte S; El Mansari M; Pershon A; Schloss P; Sánchez C; Haddjeri N
CNS Neurosci Ther; 2016 Aug; 22(8):691-9. PubMed ID: 27171685
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.
David DJ; Bourin M; Jego G; Przybylski C; Jolliet P; Gardier AM
Br J Pharmacol; 2003 Nov; 140(6):1128-36. PubMed ID: 14530210
[TBL] [Abstract][Full Text] [Related]
20. Microdialysis monitoring of variations in extracellular levels of serotonin, GABA and excitatory amino acids in the frontal cortex of awake rats in response to a single peripheral or central administration of dexfenfluramine.
Rocher C; Bert L; Robert F; Trouvin JH; Renaud B; Jacquot C; Gardier AM
Brain Res; 1996 Oct; 737(1-2):221-30. PubMed ID: 8930369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
